Braveheart Bio, Inc. (NASDAQ:BRVE) Financings
Financings
| Raise | Date |
|---|---|
| Public offering of common stock Closed: US$439.9M in the latest tranche · US$18 a share · Goldman Sachs & Co. LLC +4 Dealers: Goldman Sachs & Co. LLC (co-lead), Jefferies (co-lead), TD Cowen (co-lead), Stifel (co-lead), Cantor (co-lead) | Sep 8, 2026 |